French regulators have authorised the first specific antidote for ricin, a toxin viewed as a serious bioterrorism threat with no prior targeted treatment.
West Conshohocken, PA, Sept. 21, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, announced today that SERB will present in vivo data for PR022, a polyclonal antibody in development as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results